This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ben-Gurion University of the Negev Research and Development Authority. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Yotam Lior: Innovator in Alpha-1-Antitrypsin Research
Introduction
Yotam Lior is a notable inventor based in Beersheba, Israel. He has made significant contributions to the field of medical research, particularly in the development of treatments for inflammatory diseases. His work is characterized by a focus on innovative protein compositions that have the potential to improve patient outcomes.
Latest Patents
Yotam Lior holds a patent for "Mutant alpha-1-antitrypsin compositions and use thereof." This invention provides mutant alpha-1-antitrypsin proteins, pharmaceutical compositions comprising these proteins, and methods for their use in treating subjects with inflammatory diseases or disorders. This patent highlights his commitment to advancing medical science and addressing critical health issues.
Career Highlights
Lior is affiliated with the Ben-Gurion University of the Negev Research and Development Authority. His role at this esteemed institution allows him to engage in cutting-edge research and collaborate with other experts in the field. His dedication to innovation is evident in his work and the impact it has on the scientific community.
Collaborations
Yotam Lior collaborates with Eli Chaim Lewis, further enhancing the scope and depth of his research. Their partnership exemplifies the importance of teamwork in scientific advancements and the pursuit of innovative solutions to complex medical challenges.
Conclusion
Yotam Lior's contributions to the field of alpha-1-antitrypsin research demonstrate his commitment to innovation and improving healthcare. His patent and collaborative efforts reflect a dedication to addressing significant medical issues through scientific inquiry and development.